These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 295516)

  • 1. The pharmacokinetic profile of pirenzepine.
    Hammer R; Koss FW
    Scand J Gastroenterol Suppl; 1979; 57():1-6. PubMed ID: 295516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and clinical studies on pirenzepine, a new antiulcer drug.
    Scand J Gastroenterol Suppl; 1979; 57():1-70. PubMed ID: 295517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of the gastric secretion inhibitor Pirenzepin].
    Hammer R; Koss FW
    Fortschr Med; 1980 Apr; 98(14):(549-54). PubMed ID: 6892811
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-ulcer agent pirenzepine (LS 519)--a tricyclic compound with particular physico-chemical properties (author's transl)].
    Eberlein W; Schmidt G; Reuter A; Kutter E
    Arzneimittelforschung; 1977 Feb; 27(2):356-9. PubMed ID: 577153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international pharmacokinetic study on pirenzepine following a single oral dose.
    Bozler G; Hammer R
    Scand J Gastroenterol Suppl; 1980; 66():27-33. PubMed ID: 6941374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirenzepine in peptic ulcer. Introduction to clinical trials reports.
    Chierichetti SM; Gaetani M; Petrin G
    Scand J Gastroenterol Suppl; 1979; 57():7-10. PubMed ID: 396661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in basic and clinical pharmacology of pirenzepine. Proceedings of the Second International Symposium on Pirenzepine. Hamburg, FRG, 8 June 1980.
    Scand J Gastroenterol Suppl; 1980; 66():1-114. PubMed ID: 6941371
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pirenzepine (Gastrozepin) on skeletal muscle contractility.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):619-23. PubMed ID: 6689440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment of recurrent duodenal ulceration with pirenzepine.
    Petrillo M; Bianchi Porro G
    Hepatogastroenterology; 1980 Oct; 27(5):369-71. PubMed ID: 7009360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirenzepine in the treatment of duodenal ulcer.
    D'Imperio N; Giuliani Piccari G; Lepore AM; Sarti F; Dal Monte PR
    Scand J Gastroenterol Suppl; 1979; 57():41-4. PubMed ID: 396656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic studies following administration of tetrazepam in rhesus monkeys].
    Staak M; Sticht G; Saternus KS; Käferstein H
    Beitr Gerichtl Med; 1982; 40():323-8. PubMed ID: 6131663
    [No Abstract]   [Full Text] [Related]  

  • 14. Pirenzepine in the treatment of gastric ulcer. A double-blind short-term clinical trial.
    Morelli A; Pelli A; Narducci F; Spadacini A
    Scand J Gastroenterol Suppl; 1979; 57():51-5. PubMed ID: 396658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirenzepine--a ligand with original binding properties to muscarinic receptors.
    Birdsall NJ; Burgen AS; Hammer R; Hulme EC; Stockton J
    Scand J Gastroenterol Suppl; 1980; 66():1-4. PubMed ID: 6941372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirenzepine versus cimetidine in the treatment of duodenal ulcer.
    Bianchi Porro G; Petrillo M; Lazzaroni M; Dal Monte PR; D'Imperio N; Giuliani Piccari G
    Scand J Gastroenterol Suppl; 1979; 57():59-62. PubMed ID: 396659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirenzepine in duodenal ulcer. A multicentre double-blind controlled clinical trial, First of two parts.
    Barbara L; Belsasso E; Bianchi Porro G; Blasi A; Caenazzo E; Chierichetti SM; Di Febo G; Di Mario F; Farini R; Giorgi-Conciato M; Grossi E; Mangiameli A; Miglioli M; Naccarato R; Petrillo M
    Scand J Gastroenterol Suppl; 1979; 57():11-5. PubMed ID: 396651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, short-term clinical trial of pirenzepine in duodenal ulcer.
    Morelli A; Narducci F; Pelli MA; Spadacini A
    Scand J Gastroenterol Suppl; 1979; 57():45-9. PubMed ID: 396657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of pirenzepine dihydrochloride on gastric ulcer evaluated by a double-blind controlled clinical study. Phase III study.
    Ishimori A; Yamagata S
    Arzneimittelforschung; 1982; 32(5):556-65. PubMed ID: 7049190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirenzepine and gastric mucus.
    Guslandi M
    Scand J Gastroenterol Suppl; 1979; 57():57. PubMed ID: 295518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.